Jeffrey Rado, MD
Disclosures: Contracted Research-cuurent-Alkermes|Contracted Research-current-Biogen Idec|Contracted Research-current-Roche|Contracted Research-Ended Aug, 30, 2020-Acadia|Speakers Bureau-Alkermes|Speakers Bureau-intracellular Therapies|Speakers Bureau-Noven|Consulting Fee-Ended June 30, 2020-Alkermes|Consulting Fee-Ended March 1, 2020-intracellular Therapies|speaking for CME program-Primed|Speaking for CME program-Ended August 15, 2020-Vindico|Consulting Fee-Ended March 1, 2020-Lundbeck
No Bio Available.